BRAF and pleomorphic xanthoastrocytoma: Sixty to seventy-eight percent of PXA tumors have been found to carry BRAF V600E mutation, which was more frequently found in PXA tumors than in any other neuroepithelial neoplasm of the CNS [5–10]; it can be detected via immunohistochemistry [20] or by molecular techniques.